Ranibizumab for subfoveal choroidal neovascularization in Bietti crystalline retinopathy.
Le Tien
V
V
Atmani
K
K
Querques
G
G
Massamba
N
N
Souied
E H
EH
D000328:Adult; D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D003460:Crystallization; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D000069579:Ranibizumab; D012164:Retinal Diseases / Q000150:complications*; D016896:Treatment Outcome; D014792:Visual Acuity
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab